Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Envoy Medical, Inc. (COCH)
USD0.74
-0.02 (-2.60%)
US NASDAQ Healthcare Medical - Devices
Address
4875 White Bear Parkway 55110
White Bear Lake, MN, US
White Bear Lake, MN, US
CEO
Brent T. Lucas
Website
envoymedical.com
IPO
2021-04-29
CIK 1840877 ISIN US29415V1098
Also trades on
NASDAQ Capital Market · ANZU (USD)
NASDAQ Capital Market · ANZUU (USD)
NASDAQ Capital Market · ANZUW (USD)
NASDAQ Capital Market · COCH (USD)
NASDAQ Capital Market · COCHW (USD)
Description
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.74
-0.02 (-2.60%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
325.7K
Beta
1.89
Float Shares
10.85M
Free Float %
52.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23% | -5.21% | +5.23% | +22.83% | -11.71% | -2.59% | -61.44% | -93.64% | -93.40% | -93.40% | -93.40% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
0.74
Low
6.00
+711.9%
Consensus
6.00
+711.9%
Median
6.00
+711.9%
High
6.00
+711.9%
DCF (Unlevered)
0.03
-96.0%
DCF (Levered)
0.06
-91.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 2 |
6.00
+711.9%
|
Quality scores
Altman Z-Score
-15.89
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+7.1% Q1'26: -15.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+17.5% Q1'26: +72.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-9,086.3% Q1'26: -15,541.0% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-9,240.7% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+4.3% Q1'26: +223.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.04×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
316.0K
est: 302.0K (+4.6%)
|
225.0K
est: 266.7K (-15.6%)
|
241.0K
est: 200.0K (+20.5%)
|
200.0K
200.0K – 200.0K
+0.0% YoY
|
14.40M
14.40M – 14.40M
+7,100.0% YoY
|
44.30M
44.30M – 44.30M
+207.6% YoY
|
90.40M
90.40M – 90.40M
+104.1% YoY
|
| EBITDA |
-29.79M
est: -302.0K (-9,763.9%)
|
-19.81M
est: -266.7K (-7,327.2%)
|
-21.97M
est: -200.0K (-10,884.0%)
|
-200.0K
-200.0K – -200.0K
+0.0% YoY
|
-14.40M
-14.40M – -14.40M
-7,100.0% YoY
|
-44.30M
-44.30M – -44.30M
-207.6% YoY
|
-90.40M
-90.40M – -90.40M
-104.1% YoY
|
| EBIT |
-29.92M
est: -302.0K (-9,807.9%)
|
-19.98M
est: -266.7K (-7,392.1%)
|
-22.27M
est: -200.0K (-11,035.0%)
|
-200.0K
-200.0K – -200.0K
+0.0% YoY
|
-14.40M
-14.40M – -14.40M
-7,100.0% YoY
|
-44.30M
-44.30M – -44.30M
-207.6% YoY
|
-90.40M
-90.40M – -90.40M
-104.1% YoY
|
| Net Income |
-29.92M
est: -18.54M (-61.4%)
|
-20.80M
est: -25.09M (+17.1%)
|
-23.76M
est: -23.32M (-1.9%)
|
-5.88M
-5.88M – -5.88M
+74.8% YoY
|
-3.72M
-3.72M – -3.72M
+36.7% YoY
|
9.02M
9.02M – 9.02M
+342.1% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
8.93M
est: 7.66M (+16.5%)
|
8.56M
est: 6.77M (+26.5%)
|
9.15M
est: 5.08M (+80.3%)
|
5.08M
5.08M – 5.08M
+0.0% YoY
|
365.45M
365.45M – 365.45M
+7,100.0% YoY
|
1.12B
1.12B – 1.12B
+207.6% YoY
|
2.29B
2.29B – 2.29B
+104.1% YoY
|
| EPS |
-2.54
est: -0.95 (-168.5%)
|
-1.49
est: -1.28 (-16.4%)
|
-1.23
est: -1.19 (-3.4%)
|
-0.30
-0.30 – -0.30
+74.8% YoY
|
-0.19
-0.19 – -0.19
+36.7% YoY
|
0.46
0.46 – 0.46
+342.1% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-20.61M
OE per share TTM
-0.83
Owner's Yield
-46.43%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
450.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
8
Total invested
624.7K
Insider transactions (90d)
1
Beneficial owners (>5%)
2
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Walleye Capital LLC | 1.14M | 5.51% | 1.14M | — | 1.14M | — | IA | Minnesota | 2024-11-13 | ↗ |
| 2 | Aristeia Capital, L.L.C. | 1.09M | 5.22% | 1.09M | — | 1.09M | — | IA, OO | Delaware | 2024-11-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
8
-19 vs prev Q
New positions
2
Closed positions
21
Increased
3
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 347.3K +8.2K (+2.4%) | 229.6K -33.6K (-12.8%) | 1.77% +0.186 pp | 0.00% +0.000 pp | USD2.49 -73.5% | 8 qtrs — |
| 2 | COLONY GROUP, LLC | 212.7K +— (+0.0%) | 140.6K -24.4K (-14.8%) | 1.09% +0.091 pp | 0.00% 0.000 pp | USD1.36 -51.5% | 5 qtrs — |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 119.1K +119.1K (+100.0%) | 78.7K +78.7K (+100.0%) | 0.61% +0.608 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 98.4K +51.8K (+111.3%) | 65.0K +28.9K (+80.1%) | 0.50% +0.284 pp | 0.00% +0.000 pp | USD1.61 -59.0% | 9 qtrs — |
| 5 | CITADEL ADVISORS LLC | 88.4K +88.4K (+100.0%) | 58.5K +58.5K (+100.0%) | 0.45% +0.451 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 6 | CIBC PRIVATE WEALTH GROUP, LLC | 77.9K +— (+0.0%) | 51.5K -8.9K (-14.8%) | 0.40% +0.033 pp | 0.00% +0.000 pp | USD1.37 -51.8% | 5 qtrs — |
| 7 | MORGAN STANLEY | 57.1K +600.0 (+1.1%) | 37.7K -6.1K (-13.9%) | 0.29% +0.027 pp | 0.00% +0.000 pp | USD2.83 -76.7% | 9 qtrs — |
| 8 | BLACKROCK, INC. | 39.9K +16.5K (+70.4%) | 26.4K +8.2K (+45.2%) | 0.20% +0.094 pp | 0.00% +0.000 pp | USD1.81 -63.5% | 6 qtrs — |
| 9 | CI PRIVATE WEALTH, LLC | 38.2K +— (+0.0%) | 25.2K -4.4K (-14.8%) | 0.19% +0.016 pp | 0.00% +0.000 pp | USD2.38 -72.3% | 7 qtrs — |
| 10 | VIRTU FINANCIAL LLC | 35.1K +21.2K (+152.6%) | 23.0K +12.0K (+109.1%) | 0.18% +0.114 pp | 0.00% +0.000 pp | USD0.71 -7.0% | 2 qtrs — |
| 11 | LPL FINANCIAL LLC | 28.4K +— (+0.0%) | 18.8K -3.3K (-14.8%) | 0.14% +0.012 pp | 0.00% +0.000 pp | USD1.42 -53.5% | 3 qtrs — |
| 12 | METEORA CAPITAL, LLC | 28.1K +681.0 (+2.5%) | 18.5K -2.7K (-12.7%) | 0.14% +0.015 pp | 0.00% -0.001 pp | USD0.77 -14.3% | 2 qtrs — |
| 13 | TWO SIGMA SECURITIES, LLC | 27.7K +27.7K (+100.0%) | 18.3K +18.3K (+100.0%) | 0.14% +0.141 pp | 0.00% +0.003 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 14 | UBS GROUP AG | 25.4K +1.3K (+5.5%) | 16.8K -1.9K (-10.2%) | 0.13% +0.017 pp | 0.00% +0.000 pp | USD1.08 -38.9% | 7 qtrs — |
| 15 | STATE STREET CORP | 23.9K +— (+0.0%) | 15.8K -2.7K (-14.8%) | 0.12% +0.010 pp | 0.00% +0.000 pp | USD4.40 -85.0% | 8 qtrs — |
| 16 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 19.0K +19.0K (+100.0%) | 12.6K +12.6K (+100.0%) | 0.10% +0.097 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 17 | BALLEW ADVISORS, INC | 10.1K +— (+0.0%) | 6.9K -2.4K (-25.4%) | 0.05% +0.004 pp | 0.00% -0.001 pp | USD0.78 -15.4% | 2 qtrs — |
| 18 | BLUESTEM WEALTH PARTNERS, LLC | 10.5K +— (+0.0%) | 6.9K -1.2K (-14.8%) | 0.05% +0.004 pp | 0.00% 0.000 pp | USD1.43 -53.8% | 5 qtrs — |
| 19 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.6K -552.0 (-13.4%) | 2.4K -836.0 (-26.2%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD1.52 -56.6% | 9 qtrs — |
| 20 | FARTHER FINANCE ADVISORS, LLC | 3.0K +— (+0.0%) | 2.0K -344.0 (-14.8%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD0.78 -15.4% | 2 qtrs — |
| 21 | AMERICAN CAPITAL ADVISORY, LLC | 2.0K +— (+0.0%) | 1.3K -229.0 (-14.8%) | 0.01% +0.001 pp | 0.00% 0.000 pp | USD3.25 -79.7% | 6 qtrs — |
| 22 | FORTITUDE FAMILY OFFICE, LLC | 2.0K +2.0K (+100.0%) | 1.3K +1.3K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 23 | WELLS FARGO & COMPANY/MN | 1.7K -200.0 (-10.3%) | 1.1K -354.0 (-23.6%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.52 -73.8% | 9 qtrs — |
| 24 | JONES FINANCIAL COMPANIES LLLP | 5.00 +5.0 (+100.0%) | 3.00 +3.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.60 +10.0% | 1 qtrs NEW |
| 25 | BANK OF AMERICA CORP /DE/ | 2.00 -5.0 (-71.4%) | 1.00 -4.0 (-80.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 -67.0% | 7 qtrs — |
| 26 | CITIGROUP INC | 1.00 -70.0 (-98.6%) | 1.00 -54.0 (-98.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs — |
| 27 | DSG CAPITAL ADVISORS, LLC | — -163.6K (-100.0%) | — -126.9K (-100.0%) | 0.00% -0.765 pp | 0.00% -0.020 pp | USD— | 5 qtrs SOLD |
| 28 | BARCLAYS PLC | — -203.0 (-100.0%) | — -157.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 29 | WEISS ASSET MANAGEMENT LP | — -242.6K (-100.0%) | — -188.2K (-100.0%) | 0.00% -1.135 pp | 0.00% -0.002 pp | USD— | 5 qtrs SOLD |
| 30 | SBI SECURITIES CO., LTD. | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 31 | ATLAS MERCHANT CAPITAL LLC | — -555.5K (-100.0%) | — -430.9K (-100.0%) | 0.00% -2.598 pp | 0.00% -0.191 pp | USD— | 9 qtrs SOLD |
| 32 | NORTHERN TRUST CORP | — -26.4K (-100.0%) | — -20.5K (-100.0%) | 0.00% -0.123 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 33 | HIGHPOINT ADVISOR GROUP LLC | — -38.7K (-100.0%) | — -30.0K (-100.0%) | 0.00% -0.181 pp | 0.00% -0.001 pp | USD— | 6 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 418.3K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 408.04 | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 1.1K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 82.76 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 191.6K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 420.34 | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 228.54 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 92.39 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 10.20 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 1.44 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
100.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+100,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-12-31 | BARCLAYS PLC | 10% Owner | — | I | Redeemable Warrants | 333,019 | 11.50 | 3.83M | 0 | — | ↗ |
| 2026-04-15 | McKhann Chas | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 0.72 | 72.0K | 100,000 | D | ↗ |
| 2026-02-12 | TAYLOR GLEN A | 10% Owner | P-Purchase | A | Warrant Shares (Series A-1) | 11,250,000 | 0.40 | 4.50M | 11,250,000 | D | ↗ |
| 2026-02-12 | Potashnick Robert | Officer | P-Purchase | A | Warrant (right to buy) | 127,500 | 0.40 | 51.0K | 127,500 | D | ↗ |
| 2026-02-12 | Patel Mona Chetan | Director | P-Purchase | A | Warrant (right to buy) | 187,500 | 0.40 | 75.0K | 187,500 | D | ↗ |
| 2026-02-12 | Lucas Brent T. | Director / Officer | P-Purchase | A | Warrant (right to buy) | 62,500 | 0.40 | 25.0K | 62,500 | D | ↗ |
| 2026-02-12 | Kantor Susan | Director | P-Purchase | A | Warrant (right to buy) | 57,690 | 0.40 | 23.1K | 57,690 | D | ↗ |
| 2026-02-12 | BRYNELSEN CHARLES | Director | P-Purchase | A | Class A Common Stock | 1,000,000 | 0.40 | 400.0K | 1,050,000 | D | ↗ |
| 2026-02-05 | Potashnick Robert | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 0.53 | 8.0K | 15,000 | D | ↗ |
| 2026-02-05 | Lucas Brent T. | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 0.53 | 106.0K | 200,000 | D | ↗ |
| 2025-12-03 | Smith-Gomez Janis | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.81 | 20.3K | 25,000 | D | ↗ |
| 2025-12-03 | Patel Mona Chetan | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.81 | 20.3K | 25,000 | D | ↗ |
| 2025-12-03 | Kantor Susan | Director | A-Award | A | Stock Option (right to buy) | 62,500 | 0.81 | 50.8K | 62,500 | D | ↗ |
| 2025-12-03 | Crowe Michael Curtis | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.81 | 20.3K | 25,000 | D | ↗ |
| 2025-12-03 | BRYNELSEN CHARLES | Director | A-Award | A | Stock Option (right to buy) | 62,500 | 0.81 | 50.8K | 62,500 | D | ↗ |
| 2025-11-28 | Lucas Brent T. | Director / Officer | A-Award | A | Class A Common Stock | 18,105 | 0.71 | 12.9K | 234,590 | D | ↗ |
| 2025-09-04 | TAYLOR GLEN A | Director / 10% Owner | D-Return | D | Warrant (right to buy) | 250,000 | 2.25 | 562.5K | 0 | I | ↗ |
| 2025-06-26 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 750,000 | 1.48 | 1.11M | 750,000 | I | ↗ |
| 2025-06-23 | Potashnick Robert | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-11 | Patel Mona Chetan | Director | P-Purchase | A | Class A Common Stock | 2,500 | 1.47 | 3.7K | 20,000 | D | ↗ |
| 2025-06-06 | Patel Mona Chetan | Director | P-Purchase | A | Class A Common Stock | 10,000 | 1.46 | 14.6K | 17,500 | D | ↗ |
| 2025-05-30 | Lucas Brent T. | Director / Officer | A-Award | A | Class A Common Stock | 7,742 | 1.29 | 10.0K | 216,485 | D | ↗ |
| 2025-05-27 | BRYNELSEN CHARLES | Director | P-Purchase | A | Class A Common Stock | 35,000 | 1.65 | 57.7K | 50,000 | D | ↗ |
| 2025-05-23 | BRYNELSEN CHARLES | Director | P-Purchase | A | Class A Common Stock | 13,000 | 1.64 | 21.4K | 15,000 | D | ↗ |
| 2025-05-22 | BRYNELSEN CHARLES | Director | P-Purchase | A | Class A Common Stock | 2,000 | 1.68 | 3.4K | 2,000 | D | ↗ |
| 2025-03-11 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 750,000 | 1.35 | 1.01M | 750,000 | I | ↗ |
| 2024-12-23 | Kantor Susan | Director | J-Other | A | Class A Common Stock | 34,705 | 0.00 | — | 77,887 | D | ↗ |
| 2024-12-23 | Anzu SPAC GP I LLC | 10% Owner | J-Other | D | Class A Common Stock, par value $0.0001 per share | 2,028,986 | 0.00 | — | 0 | D | ↗ |
| 2024-12-20 | Anzu SPAC GP I LLC | 10% Owner | C-Conversion | A | Class A Common Stock, par value $0.0001 per share | 1,028,986 | 0.00 | — | 2,028,986 | D | ↗ |
| 2024-12-11 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 500,000 | 2.20 | 1.10M | 500,000 | I | ↗ |
| 2024-12-11 | Lucas Brent T. | Director / Officer | P-Purchase | A | Warrant (right to buy) | 16,694 | 11.50 | 192.0K | 110,987 | D | ↗ |
| 2024-11-30 | Lucas Brent T. | Director / Officer | A-Award | A | Class A Common Stock | 5,165 | 1.94 | 10.0K | 208,743 | D | ↗ |
| 2024-11-20 | Patel Mona Chetan | Director | P-Purchase | A | Class A Common Stock | 2,500 | 2.28 | 5.7K | 7,500 | D | ↗ |
| 2024-11-19 | Kantor Susan | Director | J-Other | A | Class A Common Stock | 18,182 | 0.00 | — | 43,182 | D | ↗ |
| 2024-11-19 | Anzu SPAC GP I LLC | 10% Owner | J-Other | D | Class A Common Stock, par value $0.0001 per share | 1,000,000 | 0.00 | — | 1,000,000 | D | ↗ |
| 2024-09-11 | Patel Mona Chetan | Director | P-Purchase | A | Class A Common Stock | 4,000 | 3.33 | 13.3K | 5,000 | — | ↗ |
| 2024-09-09 | Patel Mona Chetan | Director | P-Purchase | A | Class A Common Stock | 1,000 | 3.20 | 3.2K | 1,000 | — | ↗ |
| 2024-08-27 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 500,000 | 2.97 | 1.49M | 500,000 | — | ↗ |
| 2024-08-08 | Crowe Michael Curtis | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.40 | 60.0K | 25,000 | — | ↗ |
| 2024-07-22 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 250,000 | 2.25 | 562.5K | 250,000 | — | ↗ |
| 2024-06-24 | Lucas Brent T. | Director / Officer | J-Other | A | Class A Common Stock | 74,784 | 0.00 | — | 195,615 | — | ↗ |
| 2024-06-07 | Crowe Michael Curtis | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | TAYLOR GLEN A | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 250,000 | 3.04 | 760.0K | 250,000 | — | ↗ |
| 2024-02-27 | TAYLOR GLEN A | Director / 10% Owner | P-Purchase | A | Warrant (right to buy) | 500,000 | 1.24 | 620.0K | 500,000 | — | ↗ |
| 2023-12-20 | Anzu SPAC GP I LLC | 10% Owner | C-Conversion | D | Series A Preferred Stock, par value $0.0001 per share | 373,333 | 3.63 | 1.36M | 2,126,667 | D | ↗ |
| 2023-11-21 | Lucas Brent T. | Director / Officer | P-Purchase | A | Class A Common Stock | 10,000 | 0.98 | 9.8K | 118,451 | — | ↗ |
| 2023-11-20 | TAYLOR GLEN A | Director / 10% Owner | J-Other | D | Series A Preferred Stock | 100,000 | 11.50 | 1.15M | 1,000,000 | — | ↗ |
| 2023-10-15 | Wells David R. | Officer | A-Award | A | Stock Option (right to buy) | 293,250 | 2.40 | 703.8K | 293,250 | — | ↗ |
| 2023-10-15 | Smith-Gomez Janis | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.40 | 60.0K | 25,000 | — | ↗ |
| 2023-10-15 | Patel Mona Chetan | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.40 | 60.0K | 25,000 | — | ↗ |
| 2023-10-15 | Lucas Brent T. | Director / Officer | A-Award | A | Stock Option (right to buy) | 879,749 | 2.40 | 2.11M | 879,749 | — | ↗ |
| 2023-10-15 | Kantor Susan | Director | A-Award | A | Stock Option (right to buy) | 62,500 | 2.40 | 150.0K | 62,500 | — | ↗ |
| 2023-10-15 | BRYNELSEN CHARLES | Director | A-Award | A | Stock Option (right to buy) | 62,500 | 2.40 | 150.0K | 62,500 | — | ↗ |
| 2023-09-29 | Wells David R. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | TAYLOR GLEN A | Director / 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 4,810,384 | — | ↗ |
| 2023-09-29 | Smith-Gomez Janis | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Patel Mona Chetan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Lucas Brent T. | Director / Officer | — | I | Class A Common Stock | 0 | 0.00 | — | 5,991 | — | ↗ |
| 2023-09-29 | Kantor Susan | Director | C-Conversion | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Huskins Priya Cherian | Director | C-Conversion | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Hirsch Daniel J. | Director / Officer | C-Conversion | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | DEWBREY DIANE L | Director | C-Conversion | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | BRYNELSEN CHARLES | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Anzu SPAC GP I LLC | 10% Owner | P-Purchase | A | Series A Preferred Stock, par value $0.0001 per share | 1,000,000 | 11.50 | 11.50M | 1,000,000 | — | ↗ |
| 2023-03-06 | BARCLAYS PLC | 10% Owner | — | I | Class A Ordinary Share, $0.0001 par value per share | 0 | 0.00 | — | 877,487 | — | ↗ |
| 2023-03-02 | Atlas Merchant Capital LLC | 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 900,000 | — | ↗ |
| 2022-10-01 | Hirsch Daniel J. | Officer | J-Other | A | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-10-01 | Haring-Smith Whitney | Officer | J-Other | D | Class B Common Stock, par value $0.0001 per share | 50,000 | 0.00 | — | 10,500,000 | — | ↗ |
| 2022-10-01 | DEWBREY DIANE L | Director | J-Other | A | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2021-03-01 | WULFSOHN WILLIAM A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Kantor Susan | Director | — | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Joy John W. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Huskins Priya Cherian | Director | — | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Harris Teresa A | Director | — | D | Class B Common Stock, par value $0.0001 per share | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Ganz Peter | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-01 | Anzu SPAC GP I LLC | 10% Owner | — | D | Class B Common Stock, par value $0.0001 per share | 12,000,000 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-5.3K
Shares Outstanding
20.80M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Brent Lucas | Chief Executive Officer & Director | 462.0K | male |
| Robert Potashnick | Interim Chief Financial Officer & Principal Accounting Officer | 180.8K | male |
| Karin Simonson | Vice President, General Counsel & Corporate Secretary | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COCH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
